Abstract: ABSTRACT: BACKGROUND: Previous research has indicated that phosphatidylserine (PS) supplementation has the potential to attenuate the serum cortisol response to acute exercise stress. Equivocal findings suggest that this effect might be dose dependent. This study aimed to examine the influence of short-term supplementation with a moderate dose of PS (600 mg per day) on plasma concentrations of cortisol, lactate, growth hormone and testosterone before, during, and following moderate intensity exercise in healthy males. METHODS: 10 healthy male subjects participated in the study. Each subject was assigned to ingest 600 mg PS or placebo per day for 10 days using a double-blind, placebo-controlled, crossover design. Serial venous blood samples were taken at rest, after a 15 minute moderate intensity exercise protocol on a cycle ergometer that consisted of five 3-minute incremental stages beginning at 65% and ending at 85% VO2max, and during a 65 minute passive recovery. Plasma samples were assessed for cortisol, growth hormone, testosterone, lactate and testosterone to cortisol ratio for treatment (PS or placebo). RESULTS: Mean peak cortisol concentrations and area under the curve (AUC) were lower following PS (39 +/- 1% and 35 +/- 0%, respectively) when compared to placebo (p<0.05). PS increased AUC for testosterone to cortisol ratio (184 +/- 5%) when compared to placebo (p<0.05). PS and placebo supplementation had no effect on lactate or growth hormone levels. CONCLUSION: The findings suggest that PS is an effective supplement for combating exercise-induced stress and preventing the physiological deterioration that can accompany too much exercise. PS supplementation promotes a desired hormonal status for athletes by blunting increases in cortisol levels.

Abstract: Following a bout of heavy resistance training, the muscle is in both a fatigued and potentiated state with subsequent muscle performance depending on the balance between these two factors. To date, there is no uniform agreement about the optimal acute recovery required between the heavy resistance training and subsequent muscle performance to gain performance benefits. The aim of the present study was to determine the recovery time required to observe enhanced muscle performance following a bout of heavy resistance training. Twenty professional rugby players performed a countermovement jump at baseline and approximately 15 s, 4, 8, 12, 16, 20, and 24 min after a bout of heavy resistance training (three sets of three repetitions at 87% one-repetition maximum squat). Power output, jump height, and peak rate of force development were determined for all countermovement jumps. Despite an initial decrease in countermovement jump performance after the heavy resistance training (P<0.001), participants' performance increased significantly following 8 min recovery (P<0.001) (i.e. jump height increased by 4.9%, s=3.0). The findings suggest that muscle performance during a countermovement jump can be markedly enhanced following bouts of heavy resistance training provided that adequate recovery (approximately 8 min) is allowed between the heavy resistance training and the explosive activity.

Abstract:

Abstract:

Abstract: Breathing rates during physical exercise suggest that, during these conditions, the high-frequency (HF) bandwidth of heart rate variability (HRV) analysis should be extended beyond conventional guidelines. However, there has been little investigation of the most appropriate choice of HF bandwidth during exercise. HRV analysis was performed in 10 males and six females during progressive bicycle exercise. Cardiac cycle (RR) interval and breath-by-breath respiratory data were simultaneously recorded. HRV powers were determined for the band-limited ranges 0.04-0.15 Hz [low-frequency (LF)], 0.15-0.4 Hz (HF 0.4) and 0.15-bf Hz (HF bf, where bf represents maximum breathing frequency). Mono-exponential functions described the relationship between HRV and work rate for each bandwidth (r=0.92-0.95) and were used to calculate the "HRV decay constant" (work rate associated with a 50% reduction in HRV power). The HRV decay constants for each bandwidth were linearly related to maximal work rate (r>0.71; P<0.001) and were substantially greater in males than in females (P<0.001). There was a significant difference between the HRV decay constants for HF 0.4 and HF bf (P<0.005) in both genders. The HRV decay constants for the LF and HF bf bandwidths appear to provide an indication of work capacity from submaximal exercise, without prior assumption regarding heart rate and its relationship with work rate.

Abstract: The purpose of the present study was twofold: firstly, to assess the reliability of various body composition methods, and secondly, to determine the ability of the methods to estimate changes in fat-free mass (FFM) following creatine (Cr) supplementation. Fifty-five healthy male athletes (weight 78.3 +/- 10.3 kg, age 21 +/- 1 years) gave informed consent to participate in this study. Subjects' FFM was estimated by hydrostatic weighing (HW), air-displacement plethysmography (ADP), bioelectrical impedance analysis (BIA), near-infrared spectroscopy (NIR), and anthropometric measurements (ANTHRO). Measurements were taken on 2 occasions separated by 7 days to assess the reliability of the methods. Following this, 30 subjects returned to the laboratory for an additional test day following 7 days of Cr supplementation (20 g.d(-1) Cr + 140 g.d(-1) dextrose) to assess each method's ability to detect acute changes in FFM. In terms of reliability, we found excellent test-retest correlations for all 5 methods, ranging from 0.983 to 0.998 (p < 0.001). The mean biases for the 5 methods were close to 0 (range -0.1 to 0.3 kg) and their 95% limits of agreement (LOAs) were within acceptable limits (HW = -1.1 to 1.7 kg; ADP = -1.1 to 1.2 kg; BIA = -1.0 to 1.0 kg; NIR = -1.4 to 1.4 kg); however, the 95% LOAs were slightly wider for ANTHRO (-2.4 to 2.6 kg). Following Cr supplementation there was a significant increase in body mass (from 77.9 +/- 10.1 kg to 78.9 +/- 10.3 kg, p = 0.000). In addition, all 5 body composition techniques detected the change in FFM to a similar degree (mean change: HW = 0.9 +/- 0.6 kg; ADP = 0.9 +/- 0.6 kg; BIA = 0.9 +/- 0.6 kg; NIR = 0.8 +/- 0.5 kg; ANTHRO = 1.0 +/- 0.7 kg; intraclass correlation coefficient = 0.962). We conclude that between-day differences in FFM estimation were within acceptable limits, with the possible exception of ANTHRO. In addition, all 5 methods provided similar measures of FFM change during acute Cr supplementation.

Abstract: Following a bout of high-intensity exercise of short duration (preload stimulus), the muscle is in both a fatigued and a potentiated (referred to as postactivation potentiation) state. Consequently, subsequent muscle performance depends on the balance between these 2 factors. To date, there is no uniform agreement about the optimal recovery required between the preload stimulus and subsequent muscle performance to gain optimal performance benefits. The aim of the present study was to determine the optimal recovery time required to observe enhanced muscle performance following the preload stimulus. Twenty-three professional rugby players (13 senior international players) performed 7 countermovement jumps (CMJs) and 7 ballistic bench throws at the following time points after a preload stimulus (3 repetition maximum [3RM]): baseline, approximately 15 seconds, and 4, 8, 12, 16, and 20 minutes. Their peak power output (PPO) was determined at each time point. Statistical analyses revealed a significant decrease in PPO for both the upper (856 +/- 121 W vs. 816 +/- 121 W, p < 0.001) and the lower (4,568 +/- 509 W vs. 4,430 +/- 495 W, p = 0.005) body when the explosive activity was performed approximately 15 seconds after the preload stimulus. However, when 12 minutes was allowed between the preload stimulus and the CMJ and ballistic bench throws, PPO was increased by 8.0 +/- 8.0% and 5.3 +/- 4.5%, respectively. Based on the above results, we conclude that muscle performance (e.g., power) can be significantly enhanced following a bout of heavy exercise (preload stimulus) in both the upper and the lower body, provided that adequate recovery (8-12 minutes) is given between the preload stimulus and the explosive activity.

Abstract: ABSTRACT: Phospholipids are essential components of all biological membranes. Phosphatidylcholine (PC) and Phosphatidylserine (PS) are Phosphatidyl-phospholipids that are required for normal cellular structure and function. The participation in physical activity often challenges a variety of physiological systems; consequently, the ability to maintain normal cellular function during activity can determine sporting performance. The participation in prolonged intense exercise has been shown to reduce circulatory choline concentrations in some individuals. As choline is a pre-cursor to the neurotransmitter Acetylcholine, this finding has encouraged researchers to investigate the hypothesis that supplementation with PC (or choline salts) could enhance sporting performance. Although the available data that evaluates the effects of PC supplementation on performance are equivocal, acute oral supplementation with PC (~0.2 g PC per kg body mass) has been demonstrated to improve performance in a variety of sporting activities where exercise has depleted circulatory choline concentrations. Short term oral supplementation with soy-derived PS (S-PS) has been reported to attenuate circulating cortisol concentrations, improve perceived well-being, and reduce perceived muscle soreness after exercise. More recently, short term oral supplementation (750 mg per day of S-PS for 10 days) has been demonstrated to improve exercise capacity during high intensity cycling and tended to increase performance during intermittent running. Although more research is warranted to determine minimum dietary Phospholipid requirements for optimal sporting performance, these findings suggest that some participants might benefit from dietary interventions that increase the intakes of PC and PS.

Abstract:

Abstract: PURPOSE: This study investigated the effects of 750 mg of soybean-derived phosphatidylserine (S-PtdSer), administered daily for 7 d prior to a bout of eccentric exercise and for 2d following exercise, on delayed onset of muscle soreness and markers of muscle damage, inflammation, and oxidative stress that followed prolonged downhill running. METHODS: Following preliminary testing and a familiarization session, eight recreationally active males repeated an individualized downhill run at -16.5% for 51.0 +/- 1.5 min at 8.7 +/- 0.3 km x h(-1) on four occasions (trials 1-4). Trials 1 and 37 were presupplementation control trials. After trials 1 and 3 the subjects received, in a double-blind and crossover fashion, either S-PtdSer or a glucose polymer placebo. Trials 2 and 3 were separated by a 4-wk washout period. Venous blood, perceived soreness ratings, and feeling states were assessed prior to exercise, after exercise, and at 24 and 48 h after exercise during each trial. RESULTS: Downhill running led to elevations in perceived soreness (P < 0.05), creatine kinase activities (P < 0.001), myoglobin concentrations (P < 0.001), interleukin-6 (IL-6) concentrations (P < 0.001), and lipid hydroperoxide concentrations (P < 0.01). However, supplementation did not significantly attenuate these responses. CONCLUSION: These results suggest that supplementation with 750 mg x d(-1) S-PtdSer for 10 d does not afford additional protection against delayed onset of muscle soreness and markers of muscle damage, inflammation, and oxidative stress that follow prolonged downhill running.

Abstract: Squash is a popular racket sport that requires intermittent activity with frequent bursts of near maximal-intensity exercise. Consequently, effective physiological and thermoregulatory responses are important contributors to performance during squash match-play. Controlled field-based simulation protocols have been introduced in a growing number of sports, which allow sports scientists to investigate changes in physiology and the efficacy of various interventions in sport-specific contexts. This study aimed to develop an exercise protocol that simulates the physiological requirements of elite squash match-play. Eight elite junior squash players (age 16.2+/-0.8 years, height 1.76+/-0.06 m, body mass 61.3+/-5.9 kg; mean+/-s) completed the following in a randomized order: (1) a squash match against a player of similar standard and (2) a squash-specific incremental exercise protocol (multistage squash test [MST]) followed by the squash simulation protocol (SSP). The multistage squash test was continued for 18.0+/-1.0 min and elicited near maximal post-MST heart rates, blood lactate concentrations and ratings of perceived exertion (198+/-9 beats.min-1, 5.7+/-1.7 mmol.l-1 and 18+/-1, respectively). The SSP was 12.2 min in length compared with mean game length during competitive matches of 10.0+/-1.6 min (P=0.27). Peak heart rates were similar during the SSP and match-play (192+/-11 and 189+/-6 beats.min-1, respectively; P=0.44). Mean exercising heart rates were similar during the SSP (180+/-8 beats.min-1) and match-play (179+/-13 beats.min-1; P=0.73). Peak blood lactate concentrations during the SSP and match-play were 3.5+/-1.5 and 2.4+/-1.2 mmol.l-1 (P=0.07), respectively. Peak ratings of perceived exertion during the SSP and match-play were similar (17+/-2 and 17+/-2, respectively; P=0.64). It was concluded that the SSP closely replicated the demands of squash match-play in elite junior squash players. Furthermore, the SSP provides coaches and scientific support staff with a controlled squash-specific exercise protocol that has potential application in the objective investigation of a range of interventions such as training programmes, nutritional supplements and strategies to maintain core body temperature.

Abstract: Phosphatidylserine (PtdSer) is a ubiquitous phospholipid species that is normally located within the inner leaflet of the cell membrane. PtdSer has been implicated in a myriad of membrane-related functions. As a cofactor for a variety of enzymes, PtdSer is thought to be important in cell excitability and communication. PtdSer has also been shown to regulate a variety of neuroendocrine responses that include the release of acetylcholine, dopamine and noradrenaline. Additionally, PtdSer has been extensively demonstrated to influence tissue responses to inflammation. Finally, PtdSer has the potential to act as an effective antioxidant, especially in response to iron-mediated oxidation.The majority of the available research that has investigated the effects of PtdSer supplementation on humans has concentrated on memory and cognitive function; patients experiencing some degree of cognitive decline have traditionally been the main focus of investigation. Although investigators have administered PtdSer through intravenous and oral routes, oral supplementation has wider appeal. Indeed, PtdSer is commercially available as an oral supplement intended to improve cognitive function, with recommended doses usually ranging from 100 to 500 mg/day. The main sources that have been used to derive PtdSer for supplements are bovine-cortex (BC-PtdSer) and soy (S-PtdSer); however, due to the possibility of transferring infection through the consumption of prion contaminated brain, S-PtdSer is the preferred supplement for use in humans. Although the pharmacokinetics of PtdSer have not been fully elucidated, it is likely that oral supplementation leads to small but quantifiable increases in the PtdSer content within the cell membrane.A small number of peer-reviewed full articles exist that investigate the effects of PtdSer supplementation in the exercising human. Early research indicated that oral supplementation with BC-PtdSer 800 mg/day moderated exercise-induced changes to the hypothalamo-pituitary-adrenal axis in untrained participants. Subsequently, this finding was extended to suggest that S-PtdSer 800 mg/day reduced the cortisol response to overtraining during weight training while improving feeling of well-being and decreasing perceived muscle soreness. However, equivocal findings from our laboratory might suggest that the dose required to undertake this neuroendocrine action may vary between participants.Interestingly, recent findings demonstrating that short-term supplementation with S-PtdSer 750 mg/day improved exercise capacity during high-intensity cycling and tended to increase performance during intermittent running might suggest an innovative application for this supplement. With the findings from the existing body of literature in mind, this article focuses on the potential effects of PtdSer supplementation in humans during and following exercise.

Abstract: PURPOSE: The purpose of the study was to investigate the effects of 750 mg of soybean-derived phosphatidylserine, administered daily for 10 d, on exercise capacity, oxygen uptake kinetic response, neuroendocrine function, and feeling states during exhaustive intermittent exercise. METHODS: Following preliminary testing, fourteen active males completed a staged intermittent exercise protocol on two further occasions (T1 and T2) separated by 16 +/- 1 d. The protocol consisted of three 10-min stages of cycling at 45, 55, and 65% VO2max, followed by a final bout at 85% VO2max that was continued until exhaustion. Approximately 5 d after T1 the subjects were assigned, in a double-blind manner, to either phosphatidylserine (PS) or placebo (P). Breath-by-breath respiratory data and heart rate were continually recorded throughout the exercise protocol, and blood samples were obtained at rest, during the rest periods within the protocol (Post-55, Post-65), at the end of exercise (Post-85), 20 min after the completion of exercise (postexercise), and the day following exercise (Post-24 h). RESULTS: The main finding of this study was that supplementation had a significant effect on exercise time to exhaustion at 85% VO2max (P = 0.005). The exercise time to exhaustion in PS increased following supplementation (7:51 +/- 1:36 to 9:51 +/- 1:42 min:s, P = 0.001), whereas P remained unchanged (8:09 +/- 0:54 to 8:02 +/- 0:54 min:s, P = 0.670). Supplementation did not significantly affect oxygen kinetic mean response times (MRT(on) and MRT(off)), serum cortisol concentrations, substrate oxidation, and feeling states during the trial. CONCLUSION: This is the first study to report improved exercise capacity following phosphatidylserine supplementation. These findings suggest that phosphatidylserine might possess potential ergogenic properties.

Abstract: PURPOSE: The aim of the study was to investigate the effects of 750 mg of soybean-derived phosphatidylserine or a glucose polymer placebo, administered daily for 10 d, on markers of oxidative stress, perceived soreness, and muscle damage initiated by intermittent exercise (designed to simulated soccer match play) immediately followed by an exhaustive run. METHODS: Following familiarization, 16 male soccer players completed an exhaustive intermittent exercise protocol on two further occasions (T1 and T2) separated by approximately 14 d. Ten days before T2, the subjects were assigned, in a double-blind manner, to receive either phosphatidylserine (PS) or a placebo (P). Exercise time to exhaustion, sprint performance, ratings of perceived exertion, and HR were recorded throughout both main exercise trials. Venous blood samples were obtained at rest (preexercise), 15 min following exercise (postexercise), 24 h after exercise (post-24 h), and 48 h after exercise (post-48 h). RESULTS: Preexercise and postexercise concentrations of plasma gamma-tocopherol were increased following supplementation in PS, although supplementation had no effect on plasma concentrations of other nonenzymatic antioxidants (vitamin C, alpha-tocopherol, retinol, and beta-carotene). Serum cortisol concentrations, perceived soreness, markers of muscle damage (creatine kinase (CK) and myoglobin (Mb)), and lipid peroxidation (hydroperoxides and conjugated diene lag times) were elevated to an equal extent in PS and P following exhaustive exercise before and following supplementation. The changes in running times to exhaustion from T1 to T2 in PS and P were 4.2 +/- 0.7 and -3.7 +/- 4.2%, respectively (P = 0.084). CONCLUSION: Supplementation with phosphatidylserine was not effective in attenuating the cortisol response, perceived soreness, and markers of muscle damage and lipid peroxidation following exhaustive running; however, supplementation tended to increase running time to exhaustion. Therefore, future research should be undertaken to investigate the potential ergogenic properties of this supplement.

Abstract: Ambulatory heart rate monitors and clinical electrocardiographic (ECG) devices are capable of measuring the length of consecutive cardiac periods (RR intervals). The aim of the study was to assess the agreement between the Polar 810s heart rate monitor (Polar) and the Reynolds digital ambulatory ECG using Pathfinder software version 8.4 (Reynolds v8.4) during cycle ergometry. For this purpose, eight subjects completed incremental cycling exercise that began at 60 W and increased by 30 W each 2-minute period until volitional fatigue. Simultaneous recording of the ECG (Reynolds Pathfinder), RR interval (Polar), and respiratory parameters (Metamax 3B) were undertaken at rest and throughout the exercise period. No significant differences were found in RR intervals measured by Polar and Reynolds v8.4 at any relative intensity. Polar and Reynolds v8.4 displayed strong linear relationships at all relative intensities (r2=0.927 to 0.998). Bland and Altman analyses between Polar and Reynolds v8.4 consistently demonstrated minimal bias in absolute RR interval (<0.10 ms) and the limits of agreement for group differences in RR interval and heart rate were less than +/- 10 ms and +/- 2 beats.min (-1) for all relative intensities, respectively. Power spectral analysis provided similar results for both systems in all bandwidths studied during rest and low intensity exercise. However, significant differences and large relative limits of agreement (>100 % of mean of paired means) were identified in UF at intensities > 40 % VO2max, HF at intensities > 60 % VO2max and LF during exercise at 80-100 % VO2max. These findings demonstrate that RR intervals and heart rate measurements obtained using Polar and Reynolds v8.4 are in good agreement. However, caution should be exercised when interpreting spectral analysis of RR interval data derived from different acquisition systems during physical activity.

Abstract: Exercise-induced free-radical production may be partly responsible for muscle soreness and damage following demanding exercise. A number of studies have investigated the effect of antioxidant supplementation although there is a paucity of information regarding vitamin C. Therefore the aim of the present study was to investigate the effect of vitamin C supplementation on exercise-induced muscle soreness and damage. Nine habitually active males consumed a 1 g dose of vitamin C 2 h before exercise, and on another occasion consumed an identical placebo. The exercise comprised a 90 min intermittent shuttle-running test, which was designed to simulate the multiple-sprint sports. Vitamin C supplementation increased plasma concentrations of vitamin C before exercise, and plasma concentrations continued to increase during the shuttle-run to reach a peak of approximately 200 micromol x l(-1) immediately after exercise. However, muscle soreness, and markers of both muscle damage (creatine kinase and aspartate aminotransferase) and lipid peroxidation (malondialdehyde) were elevated to an equal extent after exercise in placebo and supplemented trials. Therefore acute supplementation with vitamin C had no beneficial effects although it is possible that such short-term vitamin C supplementation was ineffective because it occurred at an inappropriate time.